$3.67
2.04% today
Nasdaq, Feb 28, 05:02 pm CET
ISIN
CH1125843347
Symbol
SOPH

SOPHiA Genetics SA Stock price

$3.60
-0.88 19.64% 1M
-0.01 0.28% 6M
+0.53 17.26% YTD
-1.39 27.86% 1Y
-9.20 71.88% 3Y
-13.16 78.52% 5Y
-13.16 78.52% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.09 2.44%
ISIN
CH1125843347
Symbol
SOPH

Key metrics

Market capitalization $235.35m
Enterprise Value $171.23m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.66
P/S ratio (TTM) P/S ratio 3.65
P/B ratio (TTM) P/B ratio 2.11
Revenue growth (TTM) Revenue growth 9.85%
Revenue (TTM) Revenue $64.49m
EBIT (operating result TTM) EBIT $-68.29m
Free Cash Flow (TTM) Free Cash Flow $-44.03m
Cash position $95.79m
EPS (TTM) EPS $-1.09
P/E forward negative
P/S forward 3.61
EV/Sales forward 2.63
Short interest 0.04%
Show more

Is SOPHiA Genetics SA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

SOPHiA Genetics SA Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a SOPHiA Genetics SA forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a SOPHiA Genetics SA forecast:

Buy
83%
Hold
17%

Financial data from SOPHiA Genetics SA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
64 64
10% 10%
100%
- Direct Costs 21 21
15% 15%
32%
44 44
8% 8%
68%
- Selling and Administrative Expenses 69 69
3% 3%
107%
- Research and Development Expense 35 35
3% 3%
54%
-60 -60
6% 6%
-93%
- Depreciation and Amortization 8.29 8.29
5% 5%
13%
EBIT (Operating Income) EBIT -68 -68
5% 5%
-106%
Net Profit -71 -71
4% 4%
-111%

In millions USD.

Don't miss a Thing! We will send you all news about SOPHiA Genetics SA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SOPHiA Genetics SA Stock News

Neutral
PRNewsWire
4 days ago
SOPHiA GENETICS enables institutions across the globe to launch world-class oncology testing BOSTON, MA and ROLLE, Switzerland, Feb. 24, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a pioneer in AI healthcare technology and a leader in data-driven medicine, announced a new milestone in the global adoption of its groundbreaking cancer testing applications MSK-ACCESS® powered with SOPHiA ...
Neutral
PRNewsWire
10 days ago
BOSTON and ROLLE, Switzerland , Feb. 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the fourth quarter and full year 2024 before U.S. markets open on Tuesday, March 4, 2025. On that day, SOPHiA GENETICS will host a conference call to discuss its financial res...
Neutral
PRNewsWire
about one month ago
The cutting-edge OncoPortal™ Mutation Tracker add-on module enables precision monitoring of evolving genomic cancer drivers BOSTON, MA and ROLLE, Switzerland , Jan. 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has unveiled the OncoPortal™ Mutation Tracker — a longitudinal MRD tracking tool desi...
More SOPHiA Genetics SA News

Company Profile

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.

Head office Switzerland
CEO Jurgi Camblong
Employees 449
Founded 2011
Website www.sophiagenetics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today